Free Trial
→ 2025 could be 'worse than the dot-com bust', says man who predicted 2008 banking crisis (From Stansberry Research) (Ad)
NYSE:ENFN

Enfusion Q1 2025 Earnings Report

Enfusion logo
$10.80 -0.01 (-0.05%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$10.85 +0.05 (+0.50%)
As of 04/17/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Earnings HistoryForecast

Enfusion EPS Results

Actual EPS
N/A
Consensus EPS
$0.06
Beat/Miss
N/A
One Year Ago EPS
N/A

Enfusion Revenue Results

Actual Revenue
N/A
Expected Revenue
$55.08 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Enfusion Announcement Details

Quarter
Q1 2025
Date
5/8/2025
Time
Before Market Opens
Conference Call Date
Thursday, May 8, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Enfusion Earnings Headlines

Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration
April 2, 2025 | businesswire.com
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN
April 2, 2025 | businesswire.com
Claim Your FREE Protection Guide
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...
April 18, 2025 | American Alternative (Ad)
Enfusion, Inc.: Enfusion Announces Fourth Quarter and Full Year 2024 Results
March 4, 2025 | finanznachrichten.de
Enfusion Announces Fourth Quarter and Full Year 2024 Results
March 3, 2025 | businesswire.com
Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion
February 26, 2025 | businesswire.com
See More Enfusion Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Enfusion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enfusion and other key companies, straight to your email.

About Enfusion

Enfusion (NYSE:ENFN) provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

View Enfusion Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles